BREAKING: U.S. regulators have authorized another COVID-19 booster of the Pfizer or Moderna vaccine for people age 50 and older. The FDA's decision aims to offer extra protection for the most vulnerable in case the virus rebounds. https://t.co/x8D4oq7I46

— The Associated Press (@AP) March 29, 2022